Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T18:09:36.464Z.
Calculation as of: 2026-10-06T18:09:36.464Z.
Quote observation: 2026-10-06T18:05:20.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ec3a954fc6de976752a3aa038aa366988fa42dfdceb22d2b84db27fd23854c8e
PE RATIO
N/A
PE RATIO AVG TTM
N/A
PE RATIO AVG 3Y
N/A
PE RATIO AVG 5Y
N/A
PE RATIO AVG 10Y
N/A
PE RATIO AVG 15Y
N/A
PE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Septerna Inc (SEPN) | $1.62B | N/A | N/A | N/A | N/A |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.62B | 15.40 | 29.99 | 47.18 | 47.18 |
| Ocular Therapeutix, Inc. (OCUL)vs › | $1.62B | N/A | N/A | N/A | N/A |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.64B | N/A | N/A | N/A | N/A |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.60B | N/A | N/A | N/A | N/A |
| Omnicell, Inc. (OMCL)vs › | $1.60B | 41.66 | 225.17 | 171.32 | 153.65 |
| Innoviva, Inc. (INVA)vs › | $1.54B | 5.10 | 13.44 | 25.81 | 17.64 |
| uniQure N.V. (QURE)vs › | $1.54B | N/A | 3.39 | 3.43 | 3.43 |
| Personalis, Inc. (PSNL)vs › | $1.70B | N/A | N/A | N/A | N/A |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.54B | N/A | 32.55 | 32.55 | 32.55 |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$35.91
Forward EPS (Est.)
$-1.35
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PE RATIO |
|---|---|
| 2025-03-27 | 7.54 |
| 2025-03-26 | 7.36 |
| 2025-03-25 | 7.31 |
| 2025-03-24 | 7.64 |
| 2025-03-21 | 7.10 |
| 2025-03-20 | 7.37 |
| 2025-03-19 | 7.85 |
| 2025-03-18 | 7.48 |
| 2025-03-17 | 7.60 |
| 2025-03-14 | 7.55 |
| 2025-03-13 | 7.66 |
| 2025-03-12 | 8.08 |
| 2025-03-11 | 8.01 |
| 2025-03-10 | 7.04 |
| 2025-03-07 | 7.71 |
| 2025-03-06 | 7.63 |
| 2025-03-05 | 7.11 |
| 2025-03-04 | 7.39 |
| 2025-03-03 | 7.27 |
| 2025-02-28 | 7.76 |
| 2025-02-27 | 6.95 |
| 2025-02-26 | 6.83 |
| 2025-02-25 | 6.62 |
| 2025-02-24 | 6.87 |
| 2025-02-21 | 6.95 |
| 2025-02-20 | 7.06 |
| 2025-02-19 | 6.65 |
| 2025-02-18 | 8.24 |
| 2025-02-14 | 15.54 |
| 2025-02-13 | 13.85 |
| 2025-02-12 | 13.57 |
| 2025-02-11 | 13.65 |
| 2025-02-10 | 15.79 |
| 2025-02-07 | 15.70 |
| 2025-02-06 | 17.04 |
| 2025-02-05 | 17.25 |
| 2025-02-04 | 17.43 |
| 2025-02-03 | 18.72 |
| 2025-01-31 | 20.28 |
| 2025-01-30 | 21.24 |
| 2025-01-29 | 18.65 |
| 2025-01-28 | 19.20 |
| 2025-01-27 | 19.38 |
| 2025-01-24 | 22.16 |
| 2025-01-23 | 22.04 |
| 2025-01-22 | 23.24 |
| 2025-01-21 | 22.42 |
| 2025-01-17 | 20.25 |
| 2025-01-16 | 20.36 |
| 2025-01-15 | 20.38 |
| 2025-01-14 | 20.34 |
| 2025-01-13 | 20.38 |
| 2025-01-10 | 21.57 |
| 2025-01-08 | 25.00 |
| 2025-01-07 | 24.54 |
| 2025-01-06 | 26.49 |
| 2025-01-03 | 28.41 |
| 2025-01-02 | 25.60 |
| 2024-12-31 | 27.46 |
| 2024-12-30 | 27.85 |
| 2024-12-27 | 30.37 |
| 2024-12-26 | 30.89 |
| 2024-12-24 | 31.06 |
| 2024-12-23 | 32.48 |
| 2024-12-20 | 29.11 |
| 2024-12-19 | 28.06 |
| 2024-12-18 | 26.86 |
| 2024-12-17 | 26.87 |
| 2024-12-16 | 26.01 |
| 2024-12-13 | 26.85 |
| 2024-12-12 | 27.06 |
| 2024-12-11 | 29.53 |
| 2024-12-10 | 27.59 |
| 2024-12-09 | 27.59 |
| 2024-12-06 | 30.88 |
| 2024-12-05 | 30.20 |
| 2024-12-04 | 31.25 |
| 2024-12-03 | 30.80 |
| 2024-12-02 | 29.69 |
| 2024-11-29 | 30.32 |
| 2024-11-27 | 29.71 |
| 2024-11-26 | 29.11 |
| 2024-11-25 | 27.88 |
| 2024-11-22 | 26.38 |
| 2024-11-21 | 26.13 |
| 2024-11-20 | 29.45 |
| 2024-11-19 | 31.68 |
| 2024-11-18 | 30.82 |
| 2024-11-15 | 29.49 |
| 2024-11-14 | 29.29 |
| 2024-11-13 | 30.38 |
| 2024-11-12 | 30.86 |
| 2024-11-11 | 33.32 |
| 2024-11-08 | 33.91 |
| 2024-11-07 | 34.03 |
| 2024-11-06 | 33.53 |
| 2024-11-05 | 30.04 |
| 2024-11-04 | 31.11 |
| 2024-11-01 | 28.52 |
| 2024-10-31 | 29.95 |
| 2024-10-30 | 26.66 |
| 2024-10-29 | 26.20 |
| 2024-10-28 | 27.16 |
| 2024-10-25 | 28.01 |
